Product Variations
Product # | Price | Quantity | |
---|---|---|---|
VD-IV-0267-0200-200mg | $1280 | ||
VD-IV-0267-0500-500mg | $2850 |
$1,280.00 – $2,850.00
White cyrstalline solid
204255-11-8
VD-IV-0267
C16H31N2O8P
410.4
99%min.
H2O
-20°C
Ro 64-0796/002; Tamiflu; ethyl (3r,4r,5s)-4-acetamido- 5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate
200mg, 500mg
Product # | Price | Quantity | |
---|---|---|---|
VD-IV-0267-0200-200mg | $1280 | ||
VD-IV-0267-0500-500mg | $2850 |
Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004 Aug 28-Sep 3;364(9436):759-65. [PubMed ] Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF, Vanprapar N: A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J. 2005 Feb;24(2):162-6. [PubMed ] Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. [PubMed ] de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005 Dec 22;353(25):2667-72.
Reviews
There are no reviews yet.